𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A RANDOMISED DOUBLE-BLIND PLACEBO-CONTROLLED PHASE II STUDY OF VANDETANIB PLUS DOCETAXEL / PREDNISOLONE IN PATIENTS WITH HORMONE-REFRACTORY PROSTATE CANCER

✍ Scribed by J. Horti; A. Widmark; A. Stenzl; I. Turesson; M.H. Federico; R.P. Abratt; N. Sanders; G.M. Pover; I. Bodrogi

Book ID
119618968
Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
71 KB
Volume
7
Category
Article
ISSN
1569-9056

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A phase 2 study of carboplatin plus doce
A phase 2 study of carboplatin plus docetaxel in men with metastatic hormone-refractory prostate cancer who are refractory to docetaxel
✍ Robert W. Ross; Tomasz M. Beer; Susanna Jacobus; Glenn J. Bubley; Mary-Ellen Tap πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 79 KB πŸ‘ 2 views

## Abstract ## BACKGROUND. Prostate cancer is the second leading cause of cancer mortality among men in the U.S. To the authors' knowledge, there is no proven, effective, second‐line therapy for docetaxel‐refractory disease. Recent data suggest that platinum salts may be effective when combined wi